October 23, 2020 Living human lung air sacs in tiny dishes promise to accelerate COVID-19 research.
October 12, 2020 New research from the Baric Lab suggests that an emerging strain of coronavirus known as swine acute diarrhea syndrome coronavirus (SADS-CoV) may have the potential to spread to humans as well.
October 5, 2020 One in seven Black women with breast cancer had delays in starting treatment, and Black women also had extended duration of treatment, according to a study led by researchers from the UNC-Chapel Hill Gillings School of Global Public Health and UNC's Lineberger Comprehensive Cancer Center.
Benefield honored with Michael S. O’Malley Alumni Award for research to identify racial differences in breast cancer outcomes
September 18, 2020 Halei Benefield has been named the 2020 recipient of the Michael S. O’Malley Alumni Award for Publication Excellence in Cancer Population Sciences.
September 16, 2020 Each year, more than 350,000 out-of-hospital cardiac arrests take place in the United States. An estimated 90% of the people who experience one do not survive. In a study published in the New England Journal of Medicine, a team led by Dr. Wayne Rosamond describes a new method to give bystanders life-saving access to AEDs: drone delivery.
August 31, 2020 The nonprofit EcoHealth Alliance has announced its latest program: The Emerging Infectious Diseases Southeast Asia Research Collaboration Hub. This is one of a new group of research centers supported by the National Institute of Allergy and Infectious Diseases, and faculty at the UNC Gillings School are key collaborators.
August 31, 2020 A new COVID-19 mouse model developed at the University of North Carolina at Chapel Hill captures many of the features of human disease and has helped advance a vaccine candidate to clinical trial.
August 10, 2020 The development of a safe and effective vaccine is a key step in ending the COVID-19 pandemic. A group of scientists now report that a leading candidate COVID-19 vaccine raises neutralizing antibodies and robustly protects non-human primates against SARS-CoV-2, the virus that causes COVID-19.
August 3, 2020 In an effort to further our understanding of how COVID-19 is spread, the National Science Foundation has funded a team of researchers at the Gillings School, led by Dr. Barbara Turpin, to study the SARS-CoV-2 virus' potential for aerosol transmission.
July 23, 2020 Based on positive results published as a preclinical study, potently neutralizing antibodies show promise as a therapy for preventing and treating COVID-19. The monoclonal antibodies were isolated from the blood of a couple from Wuhan, China, who were diagnosed with COVID-19.